Americord Registry

Americord is a leader in the advancement of umbilical cord blood, cord tissue, and placental tissue banking. As a private bank, Americord collects, processes, and stores newborn stem cells for future medical or therapeutic use by the family that saves them. Americord is committed to pioneering the development of new cord blood banking technologies. Under the direction of its Executive Medical Director, Dr. Robert Dracker, the company developed Cord Blood 2.0, a proprietary collection and extraction process that can harvest up to twice as many stem cells compared to a traditional cord blood collection. Based in New York, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Our Promises The highest quality stem cell preservation products and services in the industry A proven commitment to pioneering innovations that help families today and tomorrow The most value for your investment in cutting-edge medical options for your child and family